Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek +2 more
wiley +1 more source
Neuronal intranuclear inclusion disease: a diagnostic pitfall for MELAS. [PDF]
Liu X, Zhang ZS, Tao QQ.
europepmc +1 more source
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley +1 more source
Perspectives on monitoring and diagnosis of chemotherapy-induced cardiotoxicity. [PDF]
Méndez-Toro A.
europepmc +1 more source
Recurrent Septic Shock in Immunosuppressed Patients. [PDF]
Fukushima S, Fujita K, Hagiya H.
europepmc +1 more source
Improving Management of Viral Febrile Illness and Reducing the Need for Empiric Antibiotics Using VIDAS<sup>®</sup> Immunoassay for Dengue and Chikungunya: A West African Multicentric Study. [PDF]
Ravel F +11 more
europepmc +1 more source
Response to "Evaluating inconsistences, generalizability, and heterogeneity in analysis of carbetocin versus oxytocin after cesarean delivery in high-risk women". [PDF]
Maged A.
europepmc +1 more source
Federated Learning in Healthcare Ethics: A Systematic Review of Privacy-Preserving and Equitable Medical AI. [PDF]
Mir BA, Abbas SR, Lee SW.
europepmc +1 more source
The shared variance amongst the measures of individual differences and trait EI: a meta-meta-analytic comparison. [PDF]
Zadorozhny BS +3 more
europepmc +1 more source

